Researchers investigate biomarkers in fight against cancer

By Emily Ostermeyer

The Florida State U. Chemistry department recently released new cancer research focusing on biomarkers, which may lead to earlier detection of cancer in breast and prostate cancer patients.

A cancer biomarker is a type of molecule such as a protein in the body that, if detected, indicates the presence of cancer.

Dr. Amy Sang, Ph.D., a major researcher and professor in the department of chemistry and biochemistry, explained that the most lethal part of cancer is the spreading of cancer as it develops.

The earlier cancer is detected, the sooner it can be treated and, hopefully, prevented from spreading.

This is where the importance of biomarkers comes in.

“If you identify the biomarker, which is partially responsible for the spread of cancer, then you will be able to design new drugs to have it target this new target,” Sang said.

Sang and her colleagues have worked to identify these protein biomarkers.

“What you’ve done is you’ve narrowed the field,” said Robert Newcomer, a former postdoctoral student at FSU, who worked on this research. “Now, when you go in you can, if you’re trying to confirm that you have a biomarker, now you can focus on that protein instead of the thousands of proteins that are in that system.”

Amy Sang and her colleagues have been working for more than 15 years on this research, focusing on breast and prostate cancer.

Prostate cancer is the most common cancer among men in the U.S.

In 2007, a reported 29,093 men in the United States died from prostate cancer, according to the Centers for Disease Control and Prevention (CDC).

Breast cancer is the second most common cancer among women in the U.S., and was listed as the cause of death for 40,598 U.S. women in 2007, according to the CDC.

There are currently three FDA approved biomarkers for breast cancer, and one for prostate, the Prostate Specific Antigen (PSA).

The PSA is not entirely reliable, however, often producing false positives and false negatives.

“What that means is you need to do more research to get more sensitive, specific and reproducible results for breast cancer or prostate biomarkers,” Sang said.

The researchers in the FSU lab conducted complicated research methods to investigate these biomarkers.

Their research looked at the protein level, and examined the role of the surrounding cellular environment of the cell, called the stromal cells, and how that influences the spread of cancer.

“In the past, people only looked at the tumor, but not the environment,” Sang said. “We want to see those microenvironments, how they convert this benign tumor to a nasty killer. We are trying not only to understand the killer, but also the killer’s neighbors.”

Newcomer said that, though this research does not indicate a cure for cancer, earlier detection means a better chance of controlling cancer.

“It’s not a cure, it’s detection,” Newcomer said. “What the key about that early detection is, even if you don’t cure cancer, when you detect early enough, you can control cancer. Like diabetes or hypertension, those kind of diseases aren’t cured, but they’re controlled and they’re managed, and people can live their lives normally, when they’re controlled and managed.”

The funding for this research came in part from competitive grants from the Department of Defense Congressionally Directed Medical Research Program, the Susan G. Komen Breast Cancer Foundation, the Elsa U. Pardee Foundation and a Program Enhancement grant and a Developing Scholar award from FSU for Sang.

“Dr. Sang has worked really hard to get grants on it and she’s doing an amazing job doing that, because when you write a grant, you’re competing against [people] who have working cancer institutes,” said Zahraa Khamis, one of Sang’s graduate students who contributed to the research. “If the ideas are not really novel, the grants wouldn’t have been accepted.”

Through the long hours of research and persistent grant-application writing, Dr. Sang affirms the importance of her and the FSU Chemistry and Biochemistry department’s work.

“It’s extremely exciting and extremely hopeful,” Sang said. “It’s such a pleasure, a joy to have so many talented, intelligent, bright students. They are highly motivated. All of us want to cure cancer, to save lives-that’s what motivates us.”

Read more here: http://www.fsunews.com/apps/pbcs.dll/article?AID=/20110117/FSVIEW/110116026
Copyright 2026 FSView & Florida Flambeau